RPG Life Sciences subsidiary completes Actis Generics acquisition
- RPG Active Pharma completed acquisition of Actis Generics on September 24, 2026
- Actis Generics becomes a wholly owned subsidiary of RPG Active Pharma
- Transaction follows Share Purchase Agreement executed on July 29, 2026
- RPG Life Sciences confirms regulatory intimation under SEBI Listing Regulations
*this image is generated using AI for illustrative purposes only.
RPG Life Sciences Limited announced that its subsidiary, RPG Active Pharma Limited, has completed the acquisition of Actis Generics Private Limited. The transaction closed on September 24, 2026, making Actis a wholly owned subsidiary of RPG Active Pharma.
The completion follows the execution of a Share Purchase Agreement (SPA) on July 29, 2026. Under the terms of this agreement, RPG Active Pharma acquired the entire stake in Actis Generics. This move expands the group's presence in the pharmaceutical sector through its specialized subsidiary.
Transaction details
The acquisition was formalized through a filing with the National Stock Exchange and BSE. The company confirmed that effective from the closing date, Actis Generics Private Limited became a subsidiary of RPG Life Sciences. It operates as a wholly owned entity under RPG Active Pharma Limited.
| Entity | Role | Status | Date |
|---|---|---|---|
| RPG Life Sciences Ltd | Parent Company | Acquirer Group | Sep 24, 2026 |
| RPG Active Pharma Ltd | Subsidiary | Direct Acquirer | Sep 24, 2026 |
| Actis Generics Pvt Ltd | Target | Wholly Owned Subsidiary | Sep 24, 2026 |
Historical Stock Returns for RPG Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.15% | +5.87% | +9.99% | +66.28% | +20.61% | +308.90% |
How will the integration of Actis Generics impact RPG Life Sciences' consolidated revenue and EBITDA margins in the upcoming fiscal quarters?
What specific therapeutic segments or geographic markets does Actis Generics strengthen for RPG Active Pharma's existing portfolio?
Are there any anticipated regulatory approvals or manufacturing facility upgrades required to fully realize the synergies from this acquisition?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
